crizotinib 250 MG Oral Capsule [Xalkori]

RxCUI: 1148506
RxNorm name: crizotinib 250 MG Oral Capsule [Xalkori]
Display name: crizotinib 250 MG Oral Capsule [Xalkori]
Full name: crizotinib 250 MG Oral Capsule [Xalkori]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xalkori	CRIZOTINIB	Pfizer Laboratories Div Pfizer Inc	2a51b0de-47d6-455e-a94c-d2c737b04ff7	2025-07-22	Warnings, Adverse reactions	Exact identifier rxcui: 1148506

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2a51b0de-47d6-455e-a94c-d2c737b04ff7	Xalkori 250 MG Oral Capsule [PSN] · crizotinib 250 MG Oral Capsule [Xalkori] [SBD] · Xalkori 250 MG Oral Capsule [SY]	3	46	These highlights do not include all the information needed to use XALKORI ® safely and effectively. See full prescribing information for XALKORI. XALKORI ® (crizotinib) capsules, for oral use XALKORI ® (crizotinib) oral pellets Initial U.S. Approval: 2011	20250722